European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease
Richard B. Wilder, Pamela J. Schlembach, Dan Jones, Gregory M. Chronowski, Chul S. Ha, Anas Younes, Fredrick B. Hagemeister, Ibrahim Barista, Fernando Cabanillas, James D. Cox
Profundice en los temas de investigación de 'European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease'. En conjunto forman una huella única.